Drug recall
Potassium Acetate Injection, USP, Concentrated, 200 mEq (4mEq/mL); 50 mL single dose vials, 25 vials per tray…
FDA recall event 33872 · Class II · American Pharmaceutical Partners, Inc.
Key facts
| Event ID | 33872 |
|---|---|
| Recall numbers | D-039-6 |
| Recalling firm | American Pharmaceutical Partners, Inc. |
| Product type | Drugs |
| Products | Potassium Acetate Injection, USP, Concentrated, 200 mEq (4mEq/mL); 50 mL single dose vials, 25 vials per tray; Rx only, Sterile, For IV Use Only After Dilution; American Pharmaceutical Partners, Inc… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Exceeds specification for Aluminum content (12 month stability) |
| Initiation date | Oct 25, 2005 |
| City | Melrose Park |
| Country | United States |
| FEI number | 1000115163 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports